| ARCHETYPE ID | openEHR-EHR-OBSERVATION.crusade_bleeding.v0 |
|---|---|
| Concept | CRUSADE bleeding score |
| Description | An assessment tool used to stratify risk for major bleeding in patients presenting with NSTEMI or STEMI prior to initiation of treatment. |
| Use | Use to record the results for each component parameter, the total sum and grade for the CRUSADE bleeding score. |
| Purpose | To record the results for each component parameter, the total sum and grade for the CRUSADE bleeding score. |
| References | Abu-Assi E, Gracía-Acuña JM, Ferreira-González I, Peña-Gil C, Gayoso-Diz P, González-Juanatey JR. Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction. Circulation. 2010;121(22):2419–2426. doi:10.1161/CIRCULATIONAHA.109.925594. Abu-Assi E, Raposeiras-Roubin S, Lear P, et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2012;1(3):222–231. doi:10.1177/2048872612453924. Ariza-Solé A, Sánchez-Elvira G, Sánchez-Salado JC, et al. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res. 2013;132(6):652–658. doi:10.1016/j.thromres.2013.09.019. Flores-Ríos X, Couto-Mallón D, Rodríguez-Garrido J, et al. Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients. Eur Heart J Acute Cardiovasc Care. 2013;2(1):19–26. doi:10.1177/2048872612469885. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009;119(14):1873–1882. doi:10.1161/CIRCULATIONAHA.108.828541. |
| Copyright | © Apperta Foundation, openEHR Foundation |
| Authors | Author name: John Meredith Organisation: NHS Wales Informatics Service Email: john.meredith@wales.nhs.uk Date originally authored: 2019-04-03 |
| Other Details Language | Author name: John Meredith Organisation: NHS Wales Informatics Service Email: john.meredith@wales.nhs.uk Date originally authored: 2019-04-03 |
| Other Details (Language Independent) |
|
| Keywords | ACS, Acute coronary syndrome, Bleeding, CBRS, CRUSADE bleeding risk score, NSTEMI, Non-ST segment elevation myocardial infarction, PCI, percutaneous coronary intervention, prognosis, ST segment elevation myocardial infarction, STEMI, ischaemic heart disease, myocardial infarction, primary percutaneous coronary intervention, risk score |
| Lifecycle | in_development |
| UID | 406da867-ee6b-4e1b-8765-009a2ef7f74b |
| Language used | en |
| Citeable Identifier | 1246.145.2831 |
| Revision Number | 0.0.1-alpha |
| Archetype Concept Comment | CRUSADE is an acronym from the original study title: "Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines". |
| protocol | |
| Score version | Score version: The version of the score used, normally recorded as the year. |
| Extension | Extension: Additional information required to extend the model with local content or to align with other reference models/formalisms. For example: local information requirements; or additional metadata to align with FHIR. Include: All not explicitly excluded archetypes |
| data | |
| Baseline haematocrit | Baseline haematocrit: Haematocrit measured in %. 0: >=40 [Greater than or equal to 40%.] 2: 37-39.9 [Between 37 and 39.9%.] 3: 34-36.9 [Between 34 and 36.9%.] 7: 31-33.9 [Between 31 and 33.9%.] 9: <31 [Less than 31%.] |
| Creatinine clearance | Creatinine clearance: Creatinine clearance estimated using the Cockcroft-Gault equation. 0: >120 [Greater than 120 mL/min.] 7: >90-120 [Greater than 90 to 120 mL/min.] 17: >60-90 [Greater than 60 to 90 mL/min.] 28: >30-60 [Greater than 30 to 60 mL/min.] 35: >15-30 [Greater than 15 to 30 mL/min.] 39: <=15 [Less than or equal to 15 mL/min.] |
| Heart rate | Heart rate: Heart rate measured in beats/min. 0: <=70 [Less than or equal to 70 bpm.] 1: 71-80 [Between 71 and 80 bpm.] 3: 81-90 [Between 81 and 90 bpm.] 6: 91-100 [Between 91 and 100 bpm.] 8: 101-110 [Between 101 and 110 bpm.] 10: 111-120 [Between 111 and 120 bpm.] 11: >=121 [Greater than or equal to 121.] |
| Sex | Sex: Patient sex. 0: Male [Patient sex is male.] 8: Female [Patient sex is female.] |
| Signs of heart failure | Signs of heart failure: Signs of congestive heart failure at presentation? 0: No [No signs of congestive heart failure at presentation.] 7: Yes [Signs of Congestive Heart Failure at presentation.] |
| Prior vascular disease | Prior vascular disease: History of vascular disease? Prior vascular disease defined as peripheral artery disease or prior stroke. 0: No [No history of vascular disease.] 7: Yes [Patient has history of vascular disease.] |
| Diabetes mellitus | Diabetes mellitus: History of diabetes mellitus? 0: No [No history of diabetes mellitus.] 6: Yes [Patient has history of diabetes mellitus.] |
| Systolic blood pressure | Systolic blood pressure: Systolic blood pressure measured in mm Hg. Systolic blood pressure ordinal scores are duplicated between 101 and 120 mm Hg or greater than or equal to 201. 1: 121-180 [Between 121 and 180 mm Hg.] 3: 181-200 [Between 181 and 200 mm Hg.] 5: 101-120 or >=201 [Between 101 and 120 mm Hg or greater than or equal to 201.] 8: 91-100 [Between 91 and 100 mm Hg.] 10: <=90 [Systolic blood pressure is less than or equal to 90 mm Hg.] |
| Total score | Total score: Sum of the individual scores assigned for each of the contributing variables. min: >=0; max: <=91 |
| Risk grade | Risk grade: Overall CRUSADE risk score. Relative % calculated by risk score quintiles 1: <=20 [Very low risk.] 21: 21-30 [Low risk.] 31: 31-40 [Moderate risk.] 41: 41-50 [High risk.] 51: >=51 [Very high risk.] |
| events | |
| Any point in time event | Any point in time event: Default, unspecified point in time event which may be explicitly defined in a template or at run-time. |
| Other contributors | Heather Leslie, Atomica Informatics, Australia |
| Translators |